Expanding Project Leadership Through PMP Certification

Amidst the intricate landscape of pharmaceutical development, where precision and adherence to regulatory standards are paramount, the integration of aseptic manufacturing solutions and meticulous project management becomes indispensable. From small batch aseptic filler operations to cold chain pharmaceutical storage in a GMP compliant warehouse, every aspect of injectable formulation development…

Developmental Testing Of IV Solutions

Intravenous (IV) drug administration has expanded as proteins — versus the small-molecule drug products that formerly dominated — have become increasingly complicated, interacting with the body more quickly and targeting therapeutic areas more precisely. To avoid adverse effects to patients, some drugs must be diluted and administered slowly using IV…

Characterizing Novel Microparticle Encapsulated Drug Formulations – Part 2

As the demand for targeted and controlled release therapies continues to rise, microparticle encapsulated drugs emerge as increasingly desirable dosage forms among clinicians. In this second part of our series, we delve deeper into the intricate process of injectable formulation development, focusing on the crucial task of characterizing and understanding…

Approach To Simplifying Aseptic Contract Manufacturing – Part 2: Documentation

In our ongoing exploration of aseptic manufacturing solutions, this second installment delves deeper into the operational efficiencies brought forth by the Cytiva SA25 Aseptic Filling Workcell, utilized by Singota Solutions (the very first in North America to employ the SA25). This installment focuses on how this state-of-the-art small batch aseptic…

Approach To Simplifying Aseptic Contract Manufacturing

Navigating the intricacies of pharmaceutical and biologic clinical trials demands agile supply chain management, especially when facing sudden demands for clinical drug product. In this inaugural piece of our series, we delve into the pivotal role of Contract Development and Manufacturing Organizations like Singota Solutions (Bloomington, Indiana CDMO) in meeting…

Specializing In Small And Early-Stage Partners, Not Just Small Batches

Navigating a complex landscape, small pharmaceutical firms seek aseptic manufacturing solutions that cater to their specific needs. This is where Singota Solutions (Bloomington, Indiana CDMO) steps in, offering expertise in small batch aseptic filler technologies and specialized capabilities in injectable formulation development. With a focus on bridging the gap for…

Transitioning From Academic Research To Pharmaceutical Industry Drug Formulation And Analytical Development

Embarking on a career transition from academic research to industry demands a nuanced understanding of the diverse demands and objectives shaping each realm. At Singota Solutions (Bloomington, Indiana CDMO), we recognize the challenges and opportunities inherent in this shift, particularly in the realm of injectable formulation development. In this article,…

Challenges and Solutions in Biologic Therapies Product Manufacturing

In the intricate realm of injectable formulation development, crafting effective solutions for biologic therapies demands meticulous attention to detail and innovative approaches. Unlike conventional small molecule products, biologics necessitate specialized small batch aseptic filler techniques (Singota Solution's specialty) tailored to their unique properties and parenteral administration requirements. Formulation scientists and…

Advancing Aseptic Filling: Evaluating The Revolutionary SA25 Workcell

In the ever-evolving landscape of injectable formulation development, aseptic filling, and aseptic manufacturing solutions, the SA25 Workcell, a groundbreaking innovation crafted by Vanrx (now Cytiva) that Singota Solution's (CDMO in Bloomington, Indiana) pioneered in North America, emerges as a beacon of progress. This state-of-the-art technology represents a significant leap in…

Posts navigation